Tobramycin belongs to the aminoglycoside class of antibiotics. Assay procedures were investigated to determine the most suitable methods for the assay of tobramycin in blood, urine, and pharmaceutical preparations. The agar-plate assay was the method of choice for determinations in urine and serum. The turbidimetric assay was selected for the assay of pharmaceutical preparations. An extraction technique is described that minimizes problems encountered in the estimation of tobramycin in urine. Sample diluents, pH, and molarity were important and were variable depending on assay methods. Evidence is presented to show binding of tobramycin to a-cellulose susceptibility discs. Iron and sodium ions demonstrated potential inhibition of tobramycin in all assay methods tested.
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Tobramycin, the official United States Adopted Names Council approved generic name for nebramycin factor 6, is a single-component antibiotic isolated from a complex consisting of biologically active factors 2, 4, 5, 5', and 6 (8) . The complex belongs to the aminoglycoside family of antibiotics and is produced by Streptomyces tenebrarius (4, 7) . Tobramycin possesses antibacterial activity against Pseudomonas sp., many members of the Enterobacteriaceae, and Staphylococcus aureus (2, 6, 9) . This publication describes microbiological assay methodology and some of the conditions which affect the in vitro activity of tobramycin.
MATERIALS AND METHODS
Assay methods. The cylinder-plate method as described by Grove and Randall (3) and the disc-plate method were used for the agar-diffusion assays. Plastic petri plates (100 by 15 mm; Falcon Plastics, Los Angeles, Calif.) contained a 10-ml base layer of uninoculated Antibiotic Medium No. 5 (Difco) with a 5-ml overlay of the same medium. The overlay was seeded with a 0.5-ml suspension of Bacillus subtilis ATCC 6633 spores (adjusted to a 50% light transmission at 530 nm) for each 100 ml of agar (3). An alternate cylinder-plate assay with a chemically defined agar was employed to study the effect of certain cations on test sensitivity. The chemically defined agar contained, per liter: L-glutamic acid, 4.5 g; glycine, 1.0 g; K2HPO4, 1.8 g; glucose, 4.0 g; MgSO4-7H20, 0.14 g; and Purified Agar (BBL), 10 g; it was adjusted to pH 7.8 with 10 N NaOH. The plates were prepared on the day of the assay and were held at room temperature until standard and sample solutions were applied. Nine plates were used for the standard curve and three plates were used for each sample to be assayed. For the disc assay, standards containing 4.0, 2.0, 1.0, 0.5, and 0.25 jAg of tobramycin activity per ml were applied to each disc (6.35-mm a-cellulose disc, BBL) at a dosage of 20,uliters/disc by use of a Hamilton microliter syringe. For the cylinder assay, standards containing 0.4, 0.3, 0.2, 0.1, 0.05, and 0.025 Ag of the antibiotic per ml were applied to each plate at a dosage of 0.2 ml per cylinder. Plates were immediately incubated at 30 or 37 C for 16 to 18 hr. The zones of inhibition were read to the nearest 0.1 mm with a Fisher-Lilly Antibiotic Zone Reader. Standard dose-response curves were constructed on semilog graph paper by plotting the average response value (millimeters) for each of the standard levels against the log of the respective doses, and by joining these plotted points with a series of straight lines.
Potency was determined by first adding or subtracting from the sample zone mean the difference between the mean of the standard level on the sample plates and the mean of the same standard level on the standard plates. The value of the adjusted sample zone was extrapolated from the standard curve, and this value was multiplied by the dilution factor for the sample to obtain the potency of that particular sample.
Performance assay for susceptibility discs. A performance assay, as described in the Code of Federal Regulations (21 CFR 147.1), was used to test disc potency. The system employed Antibiotic Medium No. 5 with B. subtilis as the test organism. The addition of 6%o NaCl to the assay medium afforded necessary reduction of sensitivity.
Turbidimetric assay system. The Autoturb assay system was incorporated in this study for the assay of certain liquid samples. The assay technique was as described by Kuzel and Kavanagh (5 (1) for the extraction of drugs from urine was used to separate tobramycin from urine. A 10-ml amount of each urine sample was added to 4.0 ml of 95% undenatured ethanol in a screw-cap test tube (15 by 150 mm). The mixture was chilled in an ice bath for S min; then 12 g of solid potassium carbonate was added to achieve saturation, and the contents were immediately mixed with a vortex mixer (Super-Mixer, Matheson Scientific) or by vigorous shaking for 30 sec. The tubes were allowed to stand until part of the ethanol phase separated to the surface. The separation of the phases was completed by slow-speed centrifugation for 5 min in a Sorvall angular centrifuge. Usually, 90 to 95% of the alcohol was separated from the urine-carbonate phase. A 2-ml amount of the alcohol containing the antibiotic was aspirated and diluted to test level with 0.1 M, pH 8 phosphate buffer. To verify complete recovery of tobramycin from urine, control urine was collected from normal individuals and used to prepare solutions containing 90, 67.5, 54.0, 31.5, 13.5, 9.0, and 4.5 pg of tobramycin per ml. After extraction, the ethanol-tobramycin solutions were diluted to the standard curve reference level with 0.1 M, pH 8 phosphate buffer and were assayed by the cylinder-plate method. For comparison, the test solutions were diluted in urine and assayed without extraction against standard material similarly prepared in urine.
Preparation and extraction of susceptibility discs for assay. Discs containing 10 and 30 pg of tobramycin activity were prepared by pipetting 20-,uliter increments of appropriate aqueous stock solutions to acellulose discs. The discs were air-dried overnight at room temperature and then stored over a desiccant. The antibiotic was extracted from the disc by use of a VirTis (Research Equipment, Gardiner, N.Y.) homogenizer. Ten discs were placed in a 25-ml microflask and suspended in 10 ml of the appropriate diluent. The discs were completely macerated by the homogenizer within 1 min, and the mass was centrifuged at high speed for S min in a Sorvall angular centrifuge.
Binding properties of tobramycin to a-cellulose paper discs were investigated by filtering several 1 l-ml samples of aqueous solutions containing either 10 or 30 pug of tobramycin per ml through a common filter paper (Whatman no. 1, approximately 6 cm). Each 11-ml sample was collected and assayed turbidimetrically.
Effect of cations on assay sensitivity. The agar media were used either unaltered or with the addition of 0.63, 1.26, and 2.52% Na+ (as NaCl) or Figures 1 and 2 illustrate the effect of diluent on the disc and cylinder-plate assay systems, respectively. The predominant diluent effect was the alteration of test sensitivity. Both the disc and cylinder assay systems increased in sensitivity as the pH was increased (alkaline). The disc assay response shown in Fig. 1 reveals that the various diluents tested had little effect on the slopes of the dose-response curves. The cylinder-plate assay system was 10-fold more sensitive than the disc assay, and dose-response variations attributable to changes of diluents were reflected by changes in 9- the slope (Fig. 2) . These results demonstrated the importance of ionic concentration and pH agreement between the sample and standard, especially if the cylinder-plate assay system was used. Use of the cylinder-plate assay necessitated careful control of test parameters; however, assay variation was considerably less than with the disc assay. For the assay of samples other than serum or urine, 0.1 M, pH 8 phosphate buffer provided the best reproducibility and sensitivity.
RESULTS AND DISCUSSION
Considerable difficulties were encountered in the estimation of tobramycin in urine when the results were obtained by diluting the samples and standards with control urine. For this reason, a modification of the extraction technique of Bastos et al. (1) was employed. The results of a comparative study done with the ethanol extraction technique and the urine compensation method are summarized in Table 1 . The samples were treated Figures 3 and 4 show the influence of diluent molarity on the cylinder and disc-plate assay systems, respectively. The molarity had a more pronounced influence on the cylinder system than on the disc system. The cylinder assay system demonstrated an enhancement of sensitivity as the molarity was decreased whereas sensitivity of the disc assay decreased as diluent molarity decreased.
Binding of tobramycin to a-cellulose discs. Table 2 summarizes the results from the extraction of 30-,ug tobramycin discs by several diluents. A variety of extraction fluids were used, and recovery of the antibiotic ranged from 30 to 76%. Fig. 5 and 6 . The addition of 0.63 % Na+ to the chemically defined agar medium produced a five-to sixfold decrease in assay sensitivity and altered the slope of the dose-response curve (Fig. 5) . Larger concentrations of Na+ were tested but caused a total loss of antibiotic inhibition when added to chemically defined agar at tested concentrations. As shown in Fig. 6 , the addition of Na+ to Antibiotic Medium No. 5 exerted a similar effect but to a lesser degree.
The addition of Fe3+ to Antibiotic Medium No. 5 produced a substantial decrease in assay sensitivity as the iron concentration was increased (Fig. 7) . This effect was also demonstrated with the chemically defined agar medium (Fig. 8) (Fig. 9) . The explanation of decreased sensitivity with Fe'+ in the presence of phosphate has not been ascertained, but one may theorize that an iron-tobramycin complex is formed which inhibits antibiotic diffusion in the agar or inactivates tobramycin.
The ionic effects of several other cations in addition to Na+ and Fe3+ were investigated. The addition of Ca, Mg, and Mn to the media appeared to have no effect on the activity of tobramycin. The effects of Cu2+, Zn2+, and Co2+ on assay sensitivity could not be ascertained because of the inhibition of microbial growth. The inhibitory effect of Fe2+ (as FeSO4) was comparable to that of Fe3+.
The cylinder-plate assay system was found to be more reproducible and sensitive than the disc assay in this study. Even though variations in pH and ion concentration were more critical for the cylinder assay system than for the disc assay system, the cylinder assay was the method of choice. When a buffer diluent was used, 0. of increasing the sensitivity of the assay as well as decreasing the inhibitory effect of certain cations. The use of phosphate buffer (0.1 M, pH 8) was satisfactory in the cylinder-plate assay for samples that did contain inhibitory cations. Optimal sensitivity for the disc assay was afforded by employing 1.0 M, pH 8 phosphate buffer. Serum required dilution with the homologous control body fluid. Obtaining a meaningful potency from urine samples required extraction of the antibiotic.
The turbidimetric assay system was the method of choice for the assay of pharmaceutical preparations of tobramycin. Reproducibility of the turbidimetric assay system was considerably better than with the agar-plate method. For n = 4, the coefficient of variance for the turbidimetric assay was 1.2% and for the cylinder-plate system, 4.7 %. These evaluations were based on assays of a bulk powder preparation conducted daily for 4 days.
